BioSmart Co.,Ltd. (KOSDAQ:038460)
3,025.00
-40.00 (-1.31%)
Last updated: Mar 28, 2025
BioSmart Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 127.17 | 17,907 | 721.31 | 1,392 | -8,737 | Upgrade
|
Depreciation & Amortization | 8,204 | 8,490 | 9,572 | 5,632 | 5,314 | Upgrade
|
Loss (Gain) From Sale of Assets | 315.55 | -16,442 | -143.33 | 341.1 | 6,353 | Upgrade
|
Asset Writedown & Restructuring Costs | 1,830 | 1,355 | 54.55 | 3,036 | -18 | Upgrade
|
Loss (Gain) From Sale of Investments | -972.67 | 1,576 | 102.27 | -283.56 | 255.17 | Upgrade
|
Loss (Gain) on Equity Investments | -2,228 | 20.7 | -321.76 | 3,042 | 200.45 | Upgrade
|
Provision & Write-off of Bad Debts | -362.6 | 1,270 | 603.54 | 149.35 | -108.6 | Upgrade
|
Other Operating Activities | 9,655 | 2,391 | 4,274 | 799.81 | -5,993 | Upgrade
|
Change in Accounts Receivable | -4,707 | -1,719 | -1,146 | -4,534 | -329.8 | Upgrade
|
Change in Inventory | 2,574 | -1,871 | -6,246 | -594.6 | -2,781 | Upgrade
|
Change in Accounts Payable | 2,983 | -4,637 | 1,972 | -2,564 | 4,385 | Upgrade
|
Change in Other Net Operating Assets | -13,708 | -7,176 | -3,138 | -5,203 | -6,027 | Upgrade
|
Operating Cash Flow | 3,708 | 1,166 | 6,289 | 1,203 | -7,487 | Upgrade
|
Operating Cash Flow Growth | 218.15% | -81.47% | 422.93% | - | - | Upgrade
|
Capital Expenditures | -6,922 | -3,113 | -4,359 | -5,332 | -8,362 | Upgrade
|
Sale of Property, Plant & Equipment | 108.4 | 811.84 | 191.4 | 1,946 | 111.85 | Upgrade
|
Cash Acquisitions | - | - | - | -26,748 | -811.75 | Upgrade
|
Divestitures | - | 24,646 | 4,000 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -1,739 | -1,804 | -1,508 | -531.3 | -890.05 | Upgrade
|
Investment in Securities | 6,558 | -29,642 | 872.1 | -1,151 | 12,134 | Upgrade
|
Other Investing Activities | 365.97 | 213.78 | -1,195 | -0.03 | 1,072 | Upgrade
|
Investing Cash Flow | -8,825 | -8,834 | -2,028 | -31,797 | 2,798 | Upgrade
|
Short-Term Debt Issued | 107,860 | 168,750 | 117,567 | 58,755 | 23,289 | Upgrade
|
Long-Term Debt Issued | 10,000 | 11,000 | 11,900 | 21,517 | 6,643 | Upgrade
|
Total Debt Issued | 117,860 | 179,750 | 129,467 | 80,272 | 29,931 | Upgrade
|
Short-Term Debt Repaid | -129,299 | -161,955 | -97,983 | -54,179 | -23,400 | Upgrade
|
Long-Term Debt Repaid | -7,717 | -11,734 | -24,931 | -7,348 | -4,449 | Upgrade
|
Total Debt Repaid | -137,016 | -173,690 | -122,914 | -61,527 | -27,848 | Upgrade
|
Net Debt Issued (Repaid) | -19,157 | 6,060 | 6,553 | 18,746 | 2,083 | Upgrade
|
Issuance of Common Stock | 7,996 | - | - | 5,850 | 1,007 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | -2,992 | Upgrade
|
Dividends Paid | - | - | -360 | - | -1,261 | Upgrade
|
Other Financing Activities | 5,946 | -150.04 | -3,686 | -0 | -20 | Upgrade
|
Financing Cash Flow | -5,025 | 8,910 | 2,507 | 24,596 | -1,183 | Upgrade
|
Foreign Exchange Rate Adjustments | 12.35 | -2.57 | -39.34 | 30.69 | -1.61 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 90.02 | -0 | -701.69 | 1,125 | 0 | Upgrade
|
Net Cash Flow | -10,040 | 1,239 | 6,027 | -4,843 | -5,874 | Upgrade
|
Free Cash Flow | -3,213 | -1,947 | 1,930 | -4,129 | -15,849 | Upgrade
|
Free Cash Flow Margin | -0.66% | -0.43% | 0.49% | -2.18% | -9.52% | Upgrade
|
Free Cash Flow Per Share | -151.61 | -60.58 | 100.52 | -215.07 | -819.09 | Upgrade
|
Cash Interest Paid | 3,327 | 4,088 | 2,567 | 1,242 | 1,232 | Upgrade
|
Cash Income Tax Paid | 8,963 | 2,924 | 2,616 | 1,280 | 7,373 | Upgrade
|
Levered Free Cash Flow | -7,160 | 201.02 | 9,029 | -14,664 | -13,265 | Upgrade
|
Unlevered Free Cash Flow | -4,261 | 3,927 | 11,777 | -13,389 | -12,503 | Upgrade
|
Change in Net Working Capital | 15,966 | 5,744 | -2,258 | 18,133 | 7,636 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.